Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project

Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project

Abstract Background SARS-CoV-2 breakthrough infections (BI) after vaccine booster dose are a relevant public health issue. Methods Multicentric longitudinal cohort study within the ORCHESTRA project, involving 63,516 health workers (HW) from 14 European settings. The study investigated the cumulativ...

Full description

Bibliographic Details
Main Authors: Stefano Porru, Maria Grazia Lourdes Monaco, Gianluca Spiteri, Angela Carta, Gulser Caliskan, Concepción Violán, Pere Torán-Monserrat, Luigi Vimercati, Silvio Tafuri, Paolo Boffetta, Francesco Saverio Violante, Emma Sala, Emanuele Sansone, Fabriziomaria Gobba, Loretta Casolari, Andreas Wieser, Christian Janke, Adonina Tardon, Marta Maria Rodriguez-Suarez, Filippo Liviero, Maria Luisa Scapellato, Marco dell’Omo, Nicola Murgia, Dana Mates, Violeta Claudia Calota, Jozef Strhársky, Mariana Mrázová, Enrico Pira, Alessandro Godono, Greta Camilla Magnano, Corrado Negro, Giuseppe Verlato, Orchestra WP5 Working Group
Format: Article
Language:English
Published: Springer 2023-07-01
Series:Journal of Epidemiology and Global Health
Subjects:
SARS-CoV-2
COVID-19 breakthrough infections
COVID-19 vaccine
Booster vaccination
Booster dose
Vaccine effectiveness
Online Access:https://doi.org/10.1007/s44197-023-00139-8

Internet

https://doi.org/10.1007/s44197-023-00139-8

Similar Items